Ai Neurology Market Report: Market Size & Forecast 2026

The AI in neurology market encompasses software platforms, imaging analysis tools, diagnostic aids, and clinical decision support systems that leverage artificial intelligence to assist neurologists in identifying and managing brain and nervous system disorders. These technologies process medical imaging such as MRI, CT, and EEG scans, analyze patient data patterns, and help detect conditions like stroke, tumors, epilepsy, and neurodegenerative diseases with greater speed and accuracy than traditional methods. Hospitals, diagnostic imaging centers, and research institutions are increasingly integrating AI-powered neurology solutions into their workflows to improve patient outcomes and reduce diagnostic time.

• •Market valued at approximately $0.73 billion globally in 2025
• •Expected to expand at 26.9% CAGR over the forecast period
• •Applications span diagnostic imaging, drug discovery, patient monitoring, and clinical decision support

The rising global burden of neurological disorders, including stroke, dementia, epilepsy, and Parkinson's disease, is a primary catalyst for market expansion, as healthcare systems seek scalable solutions to manage growing patient populations. Advances in deep learning and neural network architectures have significantly improved the accuracy of AI models in interpreting complex neuroimaging data, making these tools clinically viable and attractive to medical providers. Additionally, the push toward precision medicine and value-based care is encouraging investment in technologies that enable earlier disease detection and more personalized treatment planning.

• •Increasing prevalence of neurological disorders worldwide, with stroke and dementia cases rising significantly
• •Rapid improvements in deep learning algorithms and medical image analysis capabilities
• •Growing adoption of precision medicine approaches and demand for earlier, more accurate diagnoses

The market is typically segmented by technology type, including deep learning, machine learning, and natural language processing, as well as by application areas such as diagnostic imaging, drug discovery, and patient management. Geographically, North America leads the market due to advanced healthcare infrastructure, strong R&D investment, and favorable regulatory pathways for AI medical devices, while Europe follows with robust healthcare systems and growing clinical adoption. The Asia-Pacific region is expected to witness the fastest growth, driven by large patient populations, rising healthcare spending, and increasing awareness of AI diagnostic tools in emerging markets.

• •North America holds the largest market share, supported by advanced healthcare infrastructure and regulatory approvals
• •Europe represents a significant market with strong clinical research networks and healthcare digitization efforts
• •Asia-Pacific is projected to be the fastest-growing region, fueled by large neurological disease burden and expanding healthcare access

What are the recent trends and outlook?

The market is moving toward multimodal AI systems that combine imaging, genomics, clinical records, and wearable sensor data to provide holistic neurological assessments. Regulatory bodies are increasingly establishing clear frameworks for AI-based medical devices, which should accelerate product approvals and market entry for new solutions. As clinical evidence mounts and reimbursement pathways solidify, AI in neurology is expected to become standard practice in many healthcare settings, with the market continuing its strong growth trajectory through the early 2030s.

• •Integration of AI with wearable devices and remote monitoring for continuous neurological health tracking
• •Growing emphasis on explainable AI to build clinician trust and meet regulatory requirements
• •Expansion into drug discovery and clinical trial applications, beyond diagnostic imaging use cases